temporomandibular disorder. Temporomandibular joint disorders
Conditions
Interventions
Intervention 1: Intervention: Patients in intervention group will receive 150 units of botulinium toxin A (diluted in 1 cc normal saline) which will be injected in several points on masseter and temp
Treatment - Drugs
Intervention: Patients in intervention group will receive 150 units of botulinium toxin A (diluted in 1 cc normal saline) which will be injected in several points on masseter and temporalis muscles a
Control: The patients in placebo group firstly will receive 1 cc of normal saline which will be injected in several points on masseter and temporalis muscles, then they are followed up at the first an
Sponsors
Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria are: minimum patient's age of 18 years; the disease being diagnosed as myofascial type of temporomandibular disorder; the pain score equal or more than 30 based on visual analogue scale. Exclusion criteria: presence of connective tissue inflammatory diseases such as rheumatoid arthritis; temporomandibular disorder other than myofascial type; neuropathic pain or neurologic disorders; history of allergic reaction to botulinium toxin A; pregnancy;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's pain. Timepoint: before intervention, one month after intervention, 4 months after intervention. Method of measurement: Measurement based on visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's Psychosocial status. Timepoint: Before intervention, 1 month after, 4 months after. Method of measurement: MCGill and SCL-90R questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdis Masoudrad
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed